Releases


All 2015 Releases
Jun 24, 2015 Envarsus® XR udviser differentieret farmakokinetisk profil sammenlignet med to-gange-daglig Prograf® eller én-gang-daglig Astagraf XL® i stabile nyretransplantationspatienter  
Jun 24, 2015 Envarsus® XR Demonstrates Differentiated Pharmacokinetic Profile Compared to Twice-Daily Prograf® or Once-Daily Astagraf XL® in Stable Kidney Transplant Patients  
Jun 12, 2015 U.S. District Court Rules in Veloxis Litigation  
Jun 12, 2015 Afgørelse fra amerikansk distriktsdomstol i Veloxis retssag  
Jun 3, 2015 Warrantprogram - Veloxis Pharmaceuticals A/S udsteder nye aktier i forbindelse med udnyttelse af warrants  
Jun 3, 2015 Warrant Programme - Veloxis Pharmaceuticals A/S issues new shares in connection with exercise of warrants  
May 20, 2015 Veloxis Pharmaceuticals announces financial results for the first three months of 2015  
May 12, 2015 Veloxis Pharmaceuticals A/S er vært for en telekonference i forbindelse med offentliggørelsen af kvartalsrapporten for 1. kvartal 2015 — resultater fra 1. januar til 31. marts 2015  
May 12, 2015 Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for the first Quarter 2015 — results from 1 January to 31 March, 2015  
May 4, 2015 Envarsus® XR viser forbedret farmakokinetisk profil i afroamerikanske transplantatmodtagere  
May 4, 2015 Envarsus® XR Demonstrates Improved Pharmacokinetic Profile in African-American Transplant Recipients  
Apr 10, 2015 Warrant Programme - New Articles of Association  
Apr 10, 2015 Warrantordning - Nye vedtægter  
Mar 27, 2015 Veloxis Pharmaceuticals A/S etablerer warrantordning  
Mar 27, 2015 Veloxis Pharmaceuticals A/S establishes new Warrant Programme PDF 173.7 KB Add to Briefcase
Mar 27, 2015 Warrantprogram - Veloxis Pharmaceuticals A/S udsteder nye aktier i forbindelse med udnyttelse af warrants  
Mar 27, 2015 Warrant Programme - Veloxis Pharmaceuticals A/S issues new shares in connection with exercise of warrants  
Mar 26, 2015 Veloxis Pharmaceuticals A/S - Forløb af ordinær generalforsamling  
Mar 26, 2015 Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting  
Mar 4, 2015 Notice to Convene Annual General Meeting  
Mar 4, 2015 Indkaldelse til ordinær generalforsamling  
Mar 3, 2015 Warrantordning - Nye vedtægter  
Mar 3, 2015 Warrant Programme - New Articles of Association  
Mar 3, 2015 Veloxis Pharmaceuticals A/S establishes new Warrant Programme  
Mar 3, 2015 Veloxis Pharmaceuticals A/S etablerer warrantordning  
Mar 3, 2015 Veloxis Pharmaceuticals publishes Annual Report 2014  
Mar 3, 2015 Veloxis Pharmaceuticals offentliggør årsrapport 2014  
Feb 24, 2015 Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Annual report 2014 — results from 1 January to 31 December, 2014  
Feb 24, 2015 Veloxis Pharmaceuticals A/S er vært for en telekonference i forbindelse med offentliggørelsen af årsrapporten 2014 — resultater fra 1. januar til 31. december 2014  
Jan 21, 2015 Veloxis Pharmaceuticals Announces Updated Financial Calendar for 2015  
Jan 21, 2015 Veloxis Pharmaceuticals offentliggør opdateret finanskalendar for 2015  
Jan 14, 2015 Amerikansk distriktsdomstol fastlægger tidsplan for skriftvekslinger i Veloxis' retssag  
Jan 14, 2015 U.S. District Court Sets Briefing Schedule in Veloxis Litigation  
Jan 13, 2015 Veloxis har modtaget afgørelse fra den amerikanske sundhedsmyndighed (FDA)  
Jan 13, 2015 Veloxis Confirms Receipt of U.S. Food and Drug Administration Decision  
Showing 1-35 of 35 Page: 1  
=add release to Briefcase